Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | MDK | P21741 | 4/20 | 0.35 |
| ▸ | BDNF | P23560 | 3/20 | 0.35 |
| ▸ | PTN | P21246 | 2/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.34 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.34 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CD69 | Q07108 | 1/20 | 0.34 |
| ▸ | FGF1 | P05230 | 1/20 | 0.33 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.33 |
| ▸ | BMP2 | P12643 | 1/20 | 0.32 |
| ▸ | VEGFA | P15692 | 1/20 | 0.32 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.32 |
| ▸ | SHH | Q15465 | 1/20 | 0.32 |
| ▸ | TLR4 | O00206 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24952165 | 0.88 | MAPK1 (0.39) | MAPK1MDKBDNFPTNLGALS3 | |
| SCHEMBL18737419 | 0.87 | MDK (0.41) | MAPK1MDKBDNFPTNLGALS3 | |
| SCHEMBL24952163 | 0.87 | BDNF (0.37) | MAPK1MDKBDNFPTNLGALS3 | |
| SCHEMBL24952164 | 0.85 | MAPK1 (0.31) | MAPK1MDKBDNFPTNCD69 | |
| SCHEMBL20122306 | 0.81 | LGALS3 (0.39) | MAPK1MDKBDNFPTNLGALS3 | |
| SCHEMBL24121225 | 0.77 | LGALS3 (0.39) | MAPK1MDKBDNFPTNLGALS3 | |
| SCHEMBL22598693 | 0.75 | MDK (0.45) | MAPK1MDKBDNFPTNLGALS3 | |
| SCHEMBL23343406 | 0.74 | MDK (0.36) | MAPK1MDKBDNFPTNLGALS3 | |
| SCHEMBL21480237 | 0.73 | LGALS3 (0.44) | MAPK1MDKBDNFPTNLGALS3 | |
| SCHEMBL21316642 | 0.73 | LGALS3 (0.42) | MAPK1MDKBDNFPTNLGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230021037-A1 | HYDROGEL OF MERCAPTO-MODIFIED MACROMOLECULAR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Blafar Biotechnology (Hangzhou) Ltd (CN) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230021037-A1 | HYDROGEL OF MERCAPTO-MODIFIED MACROMOLECULAR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | NOTUM, MGMT, CTH | MAPK1 3345/4885MDK 681/4885BDNF 4416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.